Rodman & Renshaw Starts Emergent BioSolutions (EBS) at Buy
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $8.01 --0%
Rating Summary:
12 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 21 | New: 7
Rating Summary:
12 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 21 | New: 7
Join SI Premium – FREE
Rodman & Renshaw initiates coverage on Emergent BioSolutions (NYSE: EBS) with a Buy rating and a price target of $16.00.
For an analyst ratings summary and ratings history on Emergent BioSolutions click here. For more ratings news on Emergent BioSolutions click here.
Shares of Emergent BioSolutions closed at $10.49 yesterday.
You May Also Be Interested In
- UBS Starts Elevra Lithium (ELV:AU) at Buy
- TD Cowen Starts Propel Holdings (PRL:CN) at Buy
- Piper Sandler Starts Intuit (INTU) at Underweight
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
